Whole-body magnetic resonance imaging is becoming an important tool in oncology as a nonirradiating imaging technique since recent technological advances allowed the incorporation of high-quality imaging in an adequate time. Moreover, the noninjection of radioisotope/intravenous contrast, low cost compared with traditional nuclear medicine techniques, and fast acquisition times are another distinct feature. Thus, the purpose of this article is to review the whole-body magnetic resonance imaging protocol and its main applications in the oncology setting.
From the *São Paulo Cancer Institute Octavio Frias de Oliveira (ICESP) and Department of Radiology and Oncology, University of São Paulo Medical School;
†Hospital Sírio-Libanês; and
‡Siemens Ltda, Magnetic Ressonance, São Paulo, Brazil.
Received for publication February 1, 2018; accepted April 26, 2018.
Correspondence to: Regis Otaviano França Bezerra, MD, Avenida Doutor Arnaldo, 251, Cerqueira César, São Paulo, São Paulo, Brazil, 01246-000 (e-mail: firstname.lastname@example.org).
R.O.F.B. and D.Z.R. contributed equally to this work.
The authors declare no conflict of interest.
The authors state that this work has not received any funding.
Institutional review board approval was obtained, and the need for written informed consent was waived by the institutional review board.